Clinical Trial Update: Monthly Versus Two Doses of Ante-Natal Intermittent Preventive Treatment With Sulphadoxine-Pyrimethamine [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating monthly versus two-dose ante-natal intermittent preventive treatment with Sulphadoxine-Pyrimethamine for malaria prevention.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Sulphadoxine-pyrimethamine (Sulphadoxine-pyrimethamine)

Snippet

Sponsor: University College Hospital, Ibadan | Conditions: Malaria | Phase 1 | Status: UNKNOWN